Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04092179
Title Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
University of Alberta Hospital Edmonton Alberta T6G 2B7 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 1Z5 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field